This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks Set to Soar on Bullish Earnings

Cubist Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

One potential earnings short-squeeze candidate is biotechnology and drugs player Cubist Pharmaceuticals (CBST), which is set to release numbers on Wednesday after the market close. Wall Street analysts, on average, expect Cubist Pharmaceuticals to report revenue of $246.42 million on earnings of 48 cent per share.

During the last quarter, this company reported a profit of 68 cents per share. This company has beaten Wall Street estimates for the last three quarters in a row. Cubist Pharmaceuticals has averaged year-over-year revenue growth of 27.6% over the last four quarters.

The current short interest as a percentage of the float for Cubist Pharmaceuticals is pretty high at 13.8%. That means that out of the 64.11 million shares in the tradable float, 8.86 million shares are sold short by the bears. Any bullish earnings news could easily spark a monster short-squeeze for shares of CBST post-earnings.

From a technical perspective, CBST is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strong for the last two months, with shares moving higher from its low of $38.53 to its recent high of $44.95 a share. During that uptrend, shares of CBST have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed CBST within range of triggering a breakout trade post-earnings.

If you're bullish on CBST, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $44 to $44.95 a share with high volume. Look for volume on that move that registers near or above its three-month average action of 753,197 shares. If that breakout triggers, then CBST will set up to re-test or possibly take out its next major overhead resistance levels at $48.30 to $49.86 a share.

I would avoid CBST or look for short-biased trades if after earnings it fails to trigger that breakout, and then drops back below some key near-term support levels at $42.80 to $41.35 a share with high volume. If we get that move, the CBST will be trading back below both its 50-day and 200-day moving averages. Some possible downside targets off that move are $39 to $38.53 a share.

4 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,312.46 +46.47 0.27%
S&P 500 2,012.59 +1.23 0.06%
NASDAQ 4,580.2880 -13.1370 -0.29%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs